Benefit of Golimumab on Radiographic Progression Reported in Psoriatic Arthritis

  • Tue, 3/2/10 - 3:57pm
  • 0 Comments
  • 507 reads

Philadelphia—Golimumab inhibited progression of radiographic damage to joints in patients with psoriatic arthritis (PSA), according to 52-week results of the randomized, controlled the GO-REVEAL (Golimumab-Randomized Evaluation of Safety and Efficacy in Subjects with Psoriatic Arthritis Using a Human Anti-TNF Monoclonal Antibody) study reported at the ACR meeting. Arthur F. Kavanaugh, MD, of the University of California San Diego presented results a late-breaking news session.

Golimumab, an injectable anti-tumor necrosis factor (TNF



Read the full story >>